EPO bans Swiss claims
The EPO’s Enlarged Board of Appeal has ruled that Swiss-type claims are no longer permissible
So-called Swiss-type claims have been used for some 25 years to claim new therapeutic uses of medicaments, but in a decision on February 19, the EBA said they are no longer relevant, following changes to the European Patent Convention.
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.